Abstract
Background/Objectives:
No prospective study on the long-term effects of gastric resection on gastrointestinal hormonal changes in patients with normal body weight has been reported. The aim of this study was to evaluate the 1-year effect of subtotal gastrectomy on ghrelin and peptide YY (PYY)3−36 levels.
Subjects/Methods:
Eighteen patients with early gastric cancer underwent subtotal gastrectomy with Billroth I reconstruction. We assessed appetite, food intake, body composition, and ghrelin and PYY3–36 levels preoperatively and 1 year after surgery.
Results:
There were no significant difference in the preoperative daily food intake and 1 year after subtotal gastrectomy. Weight loss occurred in all study subjects; 11.7% (n=2), 55.5% (n=10) and 33.3% (n=6) of the patients lost <5%, 5–10% and >10% of their preoperative body weight, respectively. Body mass index, waist circumference and body fat significantly decreased 1 year after subtotal gastrectomy. There were no significant differences in the appetite visual analogue scale preoperatively and 1 year after subtotal gastrectomy. The plasma ghrelin concentration decreased significantly (P=0.006), whereas PYY3−36 did not show a significant change 1 year after subtotal gastrectomy.
Conclusions:
Ghrelin levels and body fat decreased significantly, whereas PYY3−36 levels as well as appetite and food intake did not change significantly 1 year after subtotal gastrectomy with normal body weight. These findings suggest that decreased ghrelin might contribute directly to reduced body fat.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adrian TE, Ferri GL, Bacarese-Hamilton AJ (1985). Human distribution and release of putative new gut hormone, peptide YY. Gastroenterology 89, 1070–1077.
Ariyasu H (2001). Stomach is major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86, 4753–4758.
Boström B, Sandh M, Lundberg D, Fridlund B (2003). A comparison of pain and health-related quality of life between two groups of cancer patients with differing average levels of pain. J Clin Nurs 12, 726–735.
Braga M, Zuliani W, Foppa L, Di Carlo V, Cristallo M (1988). Food intake and nutritional status after total gastrectomy: results of a nutritional follow-up. Br J Surg 75, 477–480.
Dornonville de la Cour C, Lindqvist A, Egecioglu E, Tung YC, Surve V, Ohlsson C et al. (2005). Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 54, 907–913.
Doucet E, Pomerleau M, Harper ME (2004). Fasting and postprandial total ghrelin remain unchanged after short-term energy restriction. J Clin Endocrinol Metab 89, 1727–1732.
Flint A, Raben A, Blundell JE, Astrup A (2000). Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24, 38–48.
Frayn KN (1983). Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55, 628–634.
Going S (1993). Detection of small changes in body composition by dual-energy X-ray absorptiometry. Am J Clin Nutr 57, 845–850.
Japanese Gastric Cancer Association (1998). Japanese Classification of Gastric Carcinoma—2nd English Edition. Gastric Cancer 1, 10–24.
Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH et al. (2004). Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 89, 5392–5396.
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008). Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247, 401–407.
le Roux CW, Bloom SR (2005). Peptide YY, appetite and food intake. Proc Nutr Soc 64, 213–216.
Lee S, Jin Kim Y, Yong Jeon T, Hoi Kim H, Woo Oh S, Park Y et al. (2006). Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study. Scand J Gastroenterol 41, 566–572.
Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L (1997). Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg 21, 416–420.
Liedman B, Andersson H, Berglund B, Bosaeus I, Hugosson I, Olbe L et al. (1996). Food intake after gastrectomy for gastric carcinoma: the role of a gastric reservoir. Br J Surg 83, 1138–1143.
McGowan BM, Bloom SR (2004). Peptide YY and appetite control. Curr Opin Pharmacol 4, 583–588.
Romijn JA, Corssmit EP, Havekes LM, Pijl H (2008). Gut-brain axis. Curr Opin Clin Nutr Metab Care 11, 518–521.
Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A (1998). Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 67, 44–49.
Tschöp M, Smiley DL, Heiman ML (2000). Ghrelin induces adiposity in rodents. Nature 407, 908–913.
Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S et al. (2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325–4328.
Acknowledgements
This work was supported by a Medical Research Institute Grant (2005-01) from Pusan National University, Busan, Korea.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Jeon, T., Lee, S., Kim, H. et al. Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight. Eur J Clin Nutr 64, 826–831 (2010). https://doi.org/10.1038/ejcn.2010.83
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.83
Keywords
This article is cited by
-
Comparison of the clinical and prognosis risk factors between endoscopic resection and radical gastrectomy for early-stage gastric cancer
World Journal of Surgical Oncology (2023)
-
Safety of early oral feeding after total laparoscopic radical gastrectomy for gastric cancer (SOFTLY): Study protocol for a randomized controlled trial
Trials (2019)
-
Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study
Obesity Surgery (2018)
-
A comparison of endoscopic submucosal dissection (ESD) and radical surgery for early gastric cancer: a retrospective study
World Journal of Surgical Oncology (2015)
-
Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy
Gastric Cancer (2014)